Literature DB >> 16955252

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.

J A Tayek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16955252     DOI： 10.1007/s00125-006-0404-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin.

Authors:  Matteo Monami; Chiara Luzzi; Caterina Lamanna; Veronica Chiasserini; Filomena Addante; Carla Maria Desideri; Giulio Masotti; Niccolò Marchionni; Edoardo Mannucci
Journal:  Diabetes Metab Res Rev       Date:  2006 Nov-Dec       Impact factor: 4.876

2.  Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.

Authors:  Scot H Simpson; Sumit R Majumdar; Ross T Tsuyuki; Dean T Eurich; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

3.  Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.

Authors:  S Hu; S Wang; B Fanelli; P A Bell; B E Dunning; S Geisse; R Schmitz; B R Boettcher
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

4.  Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.

Authors:  E Z Fisman; A Tenenbaum ; V Boyko; M Benderly; Y Adler; A Friedensohn; M Kohanovski; R Rotzak; H Schneider; S Behar; M Motro
Journal:  Clin Cardiol       Date:  2001-02       Impact factor: 2.882

5.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.

Authors:  M G Goldner; G L Knatterud; T E Prout
Journal:  JAMA       Date:  1971-11       Impact factor: 56.272

6.  Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study.

Authors:  J Olsson; G Lindberg; M Gottsäter; K Lindwall; A Sjöstrand; A Tisell; A Melander
Journal:  Diabetologia       Date:  2000-05       Impact factor: 10.122

7.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

Authors:  J M M Evans; S A Ogston; A Emslie-Smith; A D Morris
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.